Glucose Transporter Type 1 Deficiency Syndrome

Sponsored diagnostic testing programs for Glucose Transporter Type 1 Deficiency Syndrome

Glucose transporter type 1 (GLUT1) deficiency syndrome is a treatable neurometabolic disorder caused by impaired glucose transport across the blood–brain barrier, leading to seizures, developmental delay, and movement disorders. Symptoms often improve with a ketogenic diet that provides ketones as an alternative brain fuel. Genetic testing confirms the diagnosis and guides therapy.

1 program found for Glucose Transporter Type 1 Deficiency Syndrome

Programs

1 program
Invitae Unlock™

Invitae Epilepsy Panel

This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.

Neurology